RLMD · Relmada Therapeutics, Inc. · Proposed Sales
$4.21
+0.05 (+1.20%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$449.19M
Shares
106.69M
Volume · Nov 13
1.74M
Avg daily vol (3M)
1.35M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
Key facts
CIK
1553643
CUSIP
75955J402
13F (30d)
91 filings
78 filers
Visit website
Investor relations